Goldman Sachs is making positive comments on CVS Caremark (NYSE: CVS) today, telling clients to buy the stock following the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE